Report Categories
View AllRecent Articles
View All
BOLT Bolt Bio beats earnings estimates as quarterly loss narrows 38 percent but stock flat
KTTA Pasithea Therapeutics shares climb 21 percent despite reporting a far wider than expected Q4 2025 per share loss
NextEra Energy NEE Q1 2026 Earnings Beat Record Renewable Deployments and PostResult Valuation Assessment
The RD spending story behind GigaMedia Limited GIGM innovation GigaMedia Limited posts 009 per share loss no consensus estimates